STERIS plc (STE) Cash Flow Statement
A cash flow statement shows the actual cash a company generated and spent across operating, investing, and financing activities over a reporting period.
STERIS plc provides infection prevention products and services in the United States, Ireland, and internationally. It operates through three segments: Healthcare, Applied Sterilization Technologies, and Life Sciences.
Total Cash From Operating Activities Chart for STERIS plc
STERIS plc (STE) operating cash flow for FY2026 was USD 1.3B, a 16.8% change from FY2025. STERIS plc's operating cash flow moved from USD -300.0K in 1991 to USD 1.3B in 2026 over 35 years. Operating cash flow compound annual growth rate: 5-year CAGR of 14.2%, 10-year CAGR of 18.1%, 20-year CAGR of 11.1%.
Total Cash From Operating Activities (US Dollars)
R&D as % of Revenue
Compare with
Key Stats
- Market Cap
- $22.59B
- Implied Share Price
- $231.78
- Enterprise Value
- $24.34B
- Revenue (TTM)
- $5.94B
- EBITDA
- $1.60B
- Profit Margin
- 13.18%
- Trailing P/E
- 29.19
- Forward P/E
- 20.92
- Price/Book (MRQ)
- 3.16
- Price/Sales (TTM)
- 3.81
- EV/EBITDA
- 15.27
- EV/Revenue
- 4.10
- Dividend Yield
- 1.06%
- Book Value
- $73.45
- Free Cash Flow (FY2026)
- $972.40M
- Free Cash Flow Yield
- 4.30%
Snapshot as of 6th August 2026 — not point-in-time controlled, may lag the live market by a few days.